Stocks That Hit 52-Week Lows On Thursday During Thursday, 849 stocks hit new 52-week lows. Benzinga · Apr 28, 2022
Merck Clocks 50% Q1 Sales Growth Boosted By COVID-19 Treatment, Tightens FY22 EPS Outlook Merck & Co Inc's (NYSE:MRK) Q1 sales reached $15.90 billion, +50% Y/Y, beating the consensus of $14.68 billion. Excluding the foreign exchange impact, revenues were up 52%. Pharmaceutical sales increased 53% to $14.11 billion, primarily driven by molnupiravir, oncology, vaccines, and hospital acute care products. Pharmaceutical sales growth, excluding Lagevrio sales, was… Benzinga · Apr 28, 2022
‘I just need a space to cry.’ How hospitals have set up places where nurses can recharge MIAMI -- Caring for very sick children daily can be emotionally taxing, even for professionals with years of experience. As front-line workers who also support grieving parents, nurses often cope with chronic stress. Miami Herald · Apr 28, 2022
Stephens & Co. Maintains Equal-Weight Rating for Universal Health Services: Here's What You Need To Know Stephens & Co. has decided to maintain its Equal-Weight rating of Universal Health Services (NYSE:UHS) and lower its price target from $150.00 to $135.00. Shares of Universal Health Services are trading down 0.72% over the last 24 hours, at $124.42 per share. Benzinga · Apr 27, 2022
Stocks That Hit 52-Week Lows On Wednesday Wednesday's session saw 784 companies set new 52-week lows. Benzinga · Apr 27, 2022
Non-COVID Sales Boost Exact Sciences' Q1 Revenue; Revises FY22 Guidance Exact Sciences Corp's (NASDAQ:EXAS) Q1 revenues increased 21% Y/Y to $486.6 million, beating the average Wall Street estimate of $461.71 million. Excluding COVID-19 testing revenues, which dropped 15% to $27.4 million, Exact's Q1 revenue increased 24%. Screening revenues rose 28% to $306.5 million in Q1, while Precision Oncology revenues were up 18%… Benzinga · Apr 27, 2022
Stocks That Hit 52-Week Lows On Thursday On Thursday, 236 companies hit new 52-week lows. Benzinga · Apr 21, 2022